News
We would be genuinely pleased to discuss your project. So, if you have a particular need, please take a moment to fill in our contact form
Lovaltech set to produce the first clinical batches of its innovative vaccine thanks to GTP Bioways
GTP Bioways strengthens its bioproduction capacities with the opening of a new microbial production unit
LinKinVax completes first batch production of “PanCov”, its next generation multi-variant vaccine against covid and other coronaviruses, in collaboration with GTP Bioways
GTP Bioways is opening two new biopharmaceutical production units
Genother, l’excellence en thérapie génique, labellisé Biocluster du Plan France 2030
GTP Bioways increases its mammalian production capacity with the opening of a new GMP manufacturing suite
Texcell & GTP Bioways – A business partnership to provide extended services to biopharmaceutical companies
Polygon Therapeutics & GTP Bioways – Cell line development for a novel antibody
GTP Bioways will open two new biopharmaceutical production units by mid-2023
LinKinVax & GTP Bioways – Development and production of a vaccine against SARS-CoV-2
Vakona & GTP Bioways – New acne medicine takes one step closer to market launch
We offer customized solutions, contact us to discuss your project
GTP Bioways started providing custom recombinant protein production services in 2000 to accelerate biopharmaceutical development and overcome a wide range of challenges.
